Many people wait for symptoms to repeat before seeking medical help but Dr Jiri Kubes says one sign needs to be taken ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment for metastatic prostate cancer. In March, the hospital began administering ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be ...

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain ...